Celularity (CELU) Change in Accured Expenses (2019 - 2025)

Celularity (CELU) has reported Change in Accured Expenses for 7 consecutive years, with $3.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 31.54% year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $13.5 million (up 6.47% YoY), while the FY2025 annual figure was $13.5 million, up 6.47% from the prior year.
• Change in Accured Expenses improved to $3.7 million in Q4 2025 per CELU's latest filing, from $822000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $6.2 million in Q2 2025 and bottomed at -$9.2 million in Q4 2022.
• Historically, Change in Accured Expenses has averaged $1.0 million across 5 years, with a median of $1.0 million in 2023.
• On a YoY basis, Change in Accured Expenses climbed as much as 13765.96% in 2021 and fell as far as 785.75% in 2021.
• Celularity's Change in Accured Expenses stood at -$5.6 million in 2021, then plunged by 62.37% to -$9.2 million in 2022, then jumped by 70.98% to -$2.7 million in 2023, then soared by 302.82% to $5.4 million in 2024, then tumbled by 31.54% to $3.7 million in 2025.
• Business Quant data shows CELU's Change in Accured Expenses at $3.7 million in Q4 2025, $822000.0 in Q3 2025, and $6.2 million in Q2 2025.